Institutional investors purchased a net $520.6 thousand shares of CCXI during the quarter ended December 2014. This may signal that the smart money is gaining interest in this company as the 61.91% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 399.2 Thousand shares of ChemoCentryx Inc
MILLENNIUM MANAGEMENT LLC Bought 368.6 Thousand shares of ChemoCentryx Inc
FIRST MANHATTAN CO. Bought 260.5 Thousand shares of ChemoCentryx Inc